Angiotensin I-converting enzyme gene plays a crucial role in the pathology of carcinomas in colorectal cancer

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
   PubMed Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Abali H, Gullu IH, Engin H, et al. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med Hypotheses. 2002;59:344–348.
   PubMed Web of Science ®Google Scholar
• Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene. 2004;23:317–329.
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Kuriyama S, Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol. 2002;23:348–356.
   PubMed Web of Science ®Google Scholar
• Carl-McGrath S, Lendeckel U, Ebert M, et al. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol. 2004;25:1223–1232.
   PubMed Web of Science ®Google Scholar
• Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab. 2005;16:293–299.
   PubMed Web of Science ®Google Scholar
• Rieder MJ, Taylor SL, Clark AG, et al. Sequence variation in the human angiotensin converting enzyme. Nat Genet. 1999;22:59–62.
   PubMed Web of Science ®Google Scholar
• Rangel M, dos Santos JC, Ortiz PH, et al. Modification of epigenetic patterns in low birth weight children: importance of hypomethylation of the ACE gene promoter. PloS One. 2014;9:e106138.
   PubMed Web of Science ®Google Scholar
• Liu SY, Sima X, Wang CH, et al. The association between ACE polymorphism and risk of colorectal cancer in a Chinese population. Clin Biochem. 2011;44:1223–1226.
   PubMed Web of Science ®Google Scholar
• Yang H, Cai C, Ye L, et al. The relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: insights from a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2015;16:1306–1313.
   PubMed Web of Science ®Google Scholar
• Lam D, Ancelin ML, Ritchie K, et al. DNA methylation and genetic variation of the angiotensin converting enzyme (ACE) in depression. Psychoneuroendocrinology. 2018;88:1–8.
   PubMed Web of Science ®Google Scholar
• Fan R, Mao SQ, Gu TL, et al. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol Med Rep. 2017;15:3905–3911.
   PubMed Web of Science ®Google Scholar
• Rakyan VK, Down TA, Thorne NP, et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res. 2008;18:1518–1529.
   PubMed Web of Science ®Google Scholar
• Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet. 2007;8:286–298.
   PubMed Web of Science ®Google Scholar
• Ung MH, Varn FS, Lou S, et al. Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer. PLoS Comput Biol. 2015;11:e1004269.
   PubMed Web of Science ®Google Scholar
• Amabile G, Di Ruscio A, Muller F, et al. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun. 2015;6:7091.
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21.
   PubMed Web of Science ®Google Scholar
• Riviere G, Lienhard D, Andrieu T, et al. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics. 2011;6:478–489.
   PubMed Web of Science ®Google Scholar
• Rawluszko-Wieczorek AA, Horbacka K, Krokowicz P, et al. Prognostic potential of DNA methylation and transcript levels of HIF1A and EPAS1 in colorectal cancer. Mol Cancer Res. 2014;12:1112–1127.
   PubMed Web of Science ®Google Scholar
• Truong PK, Lao TD, Doan TP, et al. Loss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in Vietnamese breast cancer patients. Asian Pac J Cancer Prev. 2015;16:2209–2213.
   PubMedGoogle Scholar
• Liang YX, Mo RJ, He HC, et al. Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer. Oncol Rep. 2015;33:2648–2654.
   PubMed Web of Science ®Google Scholar
• Yang Y, Huang JQ, Zhang X, et al. MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell Biochem. 2015;404:229–239.
   PubMed Web of Science ®Google Scholar
• Tao L, Huang G, Chen Y, et al. DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell. Cancer. Biother & Radiopharm. 2015;30:100–106.
   PubMed Web of Science ®Google Scholar
• Moran A, Fernandez-Marcelo T, Carro J, et al. Methylation profiling in non-small cell lung cancer: clinical implications. Int J Oncol. 2012;40:739–746.
   PubMed Web of Science ®Google Scholar
• Moon JW, Choi JH, Lee SK, et al. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma. Cancer Genet. 2015;208:261–270.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Chen WC, Yu SL, et al. DNA hypermethylation of SHISA3 in colorectal cancer: an independent predictor of poor prognosis. Ann Surg Oncol. 2015;22:S1481–S1489.
   PubMed Web of Science ®Google Scholar
• Ding Z, Jiang T, Piao Y, et al. Meta-analysis of the association between APC promoter methylation and colorectal cancer. Onco Targets Ther. 2015;8:211–222.
   PubMed Web of Science ®Google Scholar
• Rocken C, Neumann K, Carl-McGrath S, et al. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia. 2007;9:716–722.
   PubMed Web of Science ®Google Scholar
• Toma M, Cimponeriu D, Apostol P, et al. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucur). 2009;104:553–556.
   PubMed Web of Science ®Google Scholar
• van der Knaap R, Siemes C, Coebergh JW, et al. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008;112:748–757.
   PubMed Web of Science ®Google Scholar
• Zill P, Baghai TC, Schule C, et al. DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression. PloS One. 2012;7:e40479.
   PubMed Web of Science ®Google Scholar